[HTML][HTML] Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway …
H Maarsingh, A Oldenburger, B Han, AB Zuidhof… - Cells, 2021 - mdpi.com
Expression of bronchodilatory β2-adrenoceptors and bronchoconstrictive muscarinic M3-
receptors alter with airway size. In COPD,(a combination of) β2-agonists and muscarinic M3-
antagonists (anticholinergics) are used as bronchodilators. We studied whether differential
receptor expression in large and small airways affects the response to β2-agonists and
anticholinergics in COPD. Bronchoprotection by indacaterol (β2-agonist) and glycopyrrolate
(anticholinergic) against methacholine-and EFS-induced constrictions of large and small …
receptors alter with airway size. In COPD,(a combination of) β2-agonists and muscarinic M3-
antagonists (anticholinergics) are used as bronchodilators. We studied whether differential
receptor expression in large and small airways affects the response to β2-agonists and
anticholinergics in COPD. Bronchoprotection by indacaterol (β2-agonist) and glycopyrrolate
(anticholinergic) against methacholine-and EFS-induced constrictions of large and small …
[PDF][PDF] Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway …
H Maarsingh, A Oldenburger, B Han, AB Zuidhof… - 2021 - academia.edu
Expression of bronchodilatory β2-adrenoceptors and bronchoconstrictive muscarinic M3-
receptors alter with airway size. In COPD,(a combination of) β2-agonists and muscarinic M3-
antagonists (anticholinergics) are used as bronchodilators. We studied whether differential
receptor expression in large and small airways affects the response to β2-agonists and
anticholinergics in COPD. Bronchoprotection by indacaterol (β2-agonist) and glycopyrrolate
(anticholinergic) against methacholine-and EFS-induced constrictions of large and small …
receptors alter with airway size. In COPD,(a combination of) β2-agonists and muscarinic M3-
antagonists (anticholinergics) are used as bronchodilators. We studied whether differential
receptor expression in large and small airways affects the response to β2-agonists and
anticholinergics in COPD. Bronchoprotection by indacaterol (β2-agonist) and glycopyrrolate
(anticholinergic) against methacholine-and EFS-induced constrictions of large and small …
